Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Mild”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05245903
What this trial is testing

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Who this might be right for
Alzheimer DiseaseDementia AlzheimersDementia+7 more
Mclean Hospital 40
Not applicableEnded earlyNCT02864303
What this trial is testing

Use of Saliva for Alzheimer's Disease Diagnosis

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
University Hospital, Montpellier 88
Not applicableUnknownNCT01421420
What this trial is testing

Alzheimer's Disease Core Center

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentAge-Related Memory Disorders
University of Arizona 900
Large-scale testing (Phase 3)Study completedNCT00000173
What this trial is testing

Memory Impairment Study (Mild Cognitive Impairment Study)

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)
Post-approval studies (Phase 4)Ended earlyNCT01181921
What this trial is testing

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen-Cilag, S.A. 1
Large-scale testing (Phase 3)Study completedNCT02051608
What this trial is testing

Gantenerumab in Participants With Mild Alzheimer Disease

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 389
Not applicableStudy completedNCT03937297
What this trial is testing

A Culturally Appropriate Multimodal Non-pharmacological Intervention for Chinese People With Mild-to-Moderate Dementia

Who this might be right for
Dementia
The University of Hong Kong 216
Not applicableUnknownNCT04656860
What this trial is testing

Juice Plus Supplement Clinical Trial

Who this might be right for
Cognitive ImpairmentAlzheimer Disease, Early OnsetMild Cognitive Impairment
University of Alabama, Tuscaloosa 150
Not applicableNot Yet RecruitingNCT06767124
What this trial is testing

Veech Ketone Ester to Support Brain Energy in Mild Cognitive Impairment and Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease and Related Dementias (ADRD)
University of Pennsylvania 17
Not applicableNot Yet RecruitingNCT05310890
What this trial is testing

Long Term Prospective Study of Tai Chi Intervention to Prevent MCI From Conversion to Dementia

Who this might be right for
Mild Cognitive Impairment
Ruijin Hospital 206
Not applicableUnknownNCT01436552
What this trial is testing

Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia

Who this might be right for
Mild Cognitive Impairment
Centre Hospitalier Esquirol 392
Not applicableLooking for participantsNCT07041450
What this trial is testing

Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers

Who this might be right for
Mild Cognitive ImpairmentAlzheimer DiseaseDementia
MoCA Clinic and Institute 500
Not applicableEnrolling By InvitationNCT02414178
What this trial is testing

F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)

Who this might be right for
Alzheimer Disease
Washington University School of Medicine 130
Large-scale testing (Phase 3)Ended earlyNCT05575076
What this trial is testing

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,081
Testing effectiveness (Phase 2)Study completedNCT01602393
What this trial is testing

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase

Who this might be right for
Alzheimer's Disease
Chiesi Farmaceutici S.p.A. 51
Testing effectiveness (Phase 2)Study completedNCT03880240
What this trial is testing

Gamma Induction for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Massachusetts General Hospital 17
Not applicableNot Yet RecruitingNCT07529015
What this trial is testing

Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI

Who this might be right for
Alzheimer's Disease (AD)Mild Cognitive Impairment (MCI) AmnesticCognitively Unimpaired
Institut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida) 114
Testing effectiveness (Phase 2)UnknownNCT04388982
What this trial is testing

The Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ruijin Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00785759
What this trial is testing

Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers

Who this might be right for
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
GE Healthcare 78
Not applicableUnknownNCT03551483
What this trial is testing

ArtontheBrain: An Inclusive Evidence-based Cognitive Health App for Older Adults to Promote Aging at Home

Who this might be right for
Cognitive ImpairmentMild Cognitive ImpairmentDementia+2 more
Baycrest 110
Next Page